Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.280 | 0.280 | 0.000 |
Shares | 99.720 | 99.720 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.538 | 21.748 |
Price to Book | 3.315 | 4.013 |
Price to Sales | 3.296 | 2.262 |
Price to Cash Flow | 13.855 | 16.964 |
Dividend Yield | 2.812 | 1.339 |
5 Years Earnings Growth | 6.958 | 11.136 |
Number of long holdings: 26
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Merck&Co | US58933Y1055 | 7.84 | 127.52 | -0.58% | |
J&J | US4781601046 | 6.47 | 149.26 | -0.44% | |
Pfizer | US7170811035 | 6.25 | 27.83 | +0.47% | |
Novartis | CH0012005267 | 6.18 | 87.97 | -1.01% | |
Roche Holding Participation | CH0012032048 | 5.63 | 217.30 | +1.49% | |
Eli Lilly | US5324571083 | 4.37 | 735.54 | -2.69% | |
Novo Nordisk B | DK0062498333 | 3.96 | 850.6 | -2.58% | |
AbbVie | US00287Y1091 | 3.73 | 163.79 | +1.85% | |
GSK plc | GB00BN7SWP63 | 3.73 | 1,733.50 | +0.29% | |
Daiichi Sankyo | JP3475350009 | 3.73 | 5,502.0 | +3.13% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson & Co Global Top 25 Brands | 703.2M | 6.91 | 9.10 | 13.00 | ||
Seligson Co Global Top 25 Brands Fu | 703.2M | 6.90 | 9.10 | 13.03 | ||
Seligson North American B | 470.11M | 17.21 | 15.66 | 15.17 | ||
Seligson & Co North American A | 470.11M | 17.21 | 15.67 | 15.19 | ||
Seligson & Co Europe Index Fund A | 279.5M | 8.62 | 9.19 | 7.26 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review